The B7-H4 ALSEVALI Biosimilar (HDBS0072) is a high-quality antibody designed for research involving B7-H4, a cell surface molecule with immune regulatory functions. This biosimilar antibody, created using advanced technology, is highly specific and sensitive for detecting B7-H4 in human samples.B7-H4 is known for inhibiting immune responses and has implications in various diseases, including cancer and autoimmune disorders. By targeting B7-H4 with this biosimilar antibody, researchers can gain insights into its role in immune modulation and potentially develop new therapies for these conditions.
Validated for use in Western blot applications, this biosimilar antibody enables accurate detection and analysis of B7-H4 protein in different cell types. Its reliability and specificity make it an invaluable tool for studies in immunology and cancer research, where understanding the function of B7-H4 is crucial for advancing our knowledge of immune regulation and disease pathology.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
FPA-150, FPA150
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
